Compound Q&A
What is the market or research trend for Exatecan mesylate (CAS: 169869-90-3)?
Answer
Exatecan mesylate (CAS: 169869-90-3) is primarily used in cancer chemotherapy. Market trends show growing interest in its therapeutic applications in combination therapies. Research trends focus on optimizing its delivery systems and exploring its efficacy in treating resistant tumors. There is also a trend towards developing more potent analogs and derivatives for improved therapeutic outcomes.
About
CAS No
169869-90-3
English Name
Exatecan mesylate
Molecular Formula
C25H26FN3O7S
Molecular Weight
531.56 g/mol
SMILES
CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O.CS(=O)(=O)O
InChIKey
BICYDYDJHSBMFS-GRGFAMGGSA-N
Last Updated: 2025-10-14 19:01
